ZymeTx's Series A - II Round

ZymeTx raised a round of funding on October 01, 1996.

ZymeTx is a biotechnology company that engages in the development of products for the diagnosis and treatment of viral disease, viral management, and disease surveillance. ViraZyme, its core technolog…

Articles about ZymeTx's Series A - II Round: